UK markets close in 48 minutes
  • FTSE 100

    7,137.97
    +93.94 (+1.33%)
     
  • FTSE 250

    22,829.27
    +291.38 (+1.29%)
     
  • AIM

    1,193.18
    +11.56 (+0.98%)
     
  • GBP/EUR

    1.1811
    +0.0035 (+0.29%)
     
  • GBP/USD

    1.3304
    -0.0034 (-0.25%)
     
  • BTC-GBP

    42,815.28
    +1,743.39 (+4.24%)
     
  • CMC Crypto 200

    1,426.74
    -2.19 (-0.15%)
     
  • S&P 500

    4,626.54
    +31.92 (+0.69%)
     
  • DOW

    34,905.29
    +5.95 (+0.02%)
     
  • CRUDE OIL

    70.38
    +2.23 (+3.27%)
     
  • GOLD FUTURES

    1,787.20
    -0.90 (-0.05%)
     
  • NIKKEI 225

    28,283.92
    -467.70 (-1.63%)
     
  • HANG SENG

    23,852.24
    -228.28 (-0.95%)
     
  • DAX

    15,333.46
    +76.42 (+0.50%)
     
  • CAC 40

    6,804.02
    +64.29 (+0.95%)
     

Europe Amyotrophic Lateral Sclerosis Market and Competitive Landscape Report 2021 - ResearchAndMarkets.com

·3-min read

DUBLIN, October 28, 2021--(BUSINESS WIRE)--The "Europe Amyotrophic Lateral Sclerosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Europe Amyotrophic Lateral Sclerosis Market and Competitive Landscape - 2021, provides comprehensive insights into Amyotrophic Lateral Sclerosis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.

This research analyzes and forecasts Amyotrophic Lateral Sclerosis market size and drug sales. It also provides insights into Amyotrophic Lateral Sclerosis epidemiology and late-stage pipeline.

This research covers the following - Amyotrophic Lateral Sclerosis treatment options, Amyotrophic Lateral Sclerosis late-stage clinical trials pipeline, Amyotrophic Lateral Sclerosis prevalence by countries, Amyotrophic Lateral Sclerosis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

  • Countries: Germany, France, Italy, Spain, UK, Europe

  • Amyotrophic Lateral Sclerosis pipeline: Find out drugs in clinical trials for the treatment of Amyotrophic Lateral Sclerosis by development phase 3, phase 2, by pharmacological class and company

  • Amyotrophic Lateral Sclerosis epidemiology: Find out the number of patients diagnosed (prevalence) with Amyotrophic Lateral Sclerosis by countries

  • Amyotrophic Lateral Sclerosis drugs: Identify key drugs marketed and prescribed for Amyotrophic Lateral Sclerosis in the US, including trade name, molecule name, and company

  • Amyotrophic Lateral Sclerosis drugs sales: Find out the sales value for Amyotrophic Lateral Sclerosis drugs by countries

  • Amyotrophic Lateral Sclerosis market valuations: Find out the market size for Amyotrophic Lateral Sclerosis drugs in 2020 by countries. Find out how the market advanced from 2018 and forecast to 2026

  • Amyotrophic Lateral Sclerosis drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research:

  • Evaluate commercial market opportunities for Amyotrophic Lateral Sclerosis drugs

  • Synthesize insights for business development & licensing

  • Track market size, competitor drug sales, market shares in Amyotrophic Lateral Sclerosis market

  • Develop in-depth knowledge of competition and markets

  • Analyze Amyotrophic Lateral Sclerosis drug sales data to update your brand planning trackers

  • Develop tactics and strategies to take advantage of opportunities in the market

  • Track Market Events and Trends and analyze key events in Amyotrophic Lateral Sclerosis market

  • Develop forecast models, healthcare frameworks, or economic models

  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Amyotrophic Lateral Sclerosis Treatment Options

2. Amyotrophic Lateral Sclerosis Pipeline Insights

2.1. Amyotrophic Lateral Sclerosis Phase 3 Clinical Trials

2.2. Amyotrophic Lateral Sclerosis Phase 2 Clinical Trials

2.3. Amyotrophic Lateral Sclerosis Phase 1 Clinical Trials

3. Amyotrophic Lateral Sclerosis Epidemiology Analysis by Countries

4. Germany Amyotrophic Lateral Sclerosis Market Insights

4.1. Marketed Drugs for Amyotrophic Lateral Sclerosis in Germany

4.2. Germany Amyotrophic Lateral Sclerosis Market Size & Forecast

4.3. Germany Amyotrophic Lateral Sclerosis Drugs Sales Forecast

4.4. Germany Amyotrophic Lateral Sclerosis Market Share Analysis

5. France Amyotrophic Lateral Sclerosis Market Insights

6. Italy Amyotrophic Lateral Sclerosis Market Insights

7. Spain Amyotrophic Lateral Sclerosis Market Insights

8. UK Amyotrophic Lateral Sclerosis Market Insights

9. Europe Amyotrophic Lateral Sclerosis Market Insights

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/ubbg8

View source version on businesswire.com: https://www.businesswire.com/news/home/20211028005835/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting